Global Alliance for Improved Nutrition赞助的临床试验
总计73个结果
-
University of South CarolinaGlobal Alliance for Improved Nutrition完全的
-
Swiss Federal Institute of TechnologyGlobal Alliance for Improved Nutrition; UNICEF撤销
-
University of Colorado, DenverTemple University; Purdue University; Global Alliance for Improved Nutrition完全的
-
North-West University, South AfricaGlobal Alliance for Improved Nutrition; Unilever R&D; DSM Ltd完全的
-
Swiss Federal Institute of TechnologyGlobal Alliance for Improved Nutrition; United Nations World Food Programme (WFP)完全的
-
University of TorontoEmory University; University of California, Davis; Global Alliance for Improved Nutrition; Egerton...完全的
-
University of California, DavisHelen Keller International; Cheikh Anta Diop University, Senegal; Global Alliance for Improved...完全的
-
University of California, DavisHelen Keller International; Cheikh Anta Diop University, Senegal; Global Alliance for Improved...完全的
-
Institut de Recherche pour le DeveloppementGlobal Alliance for Improved Nutrition; National Institute of Nutrition, Vietnam; Can Tho University 和其他合作者完全的
-
Centers for Disease Control and PreventionKenya Medical Research Institute; Global Alliance for Improved Nutrition; Safe Water and AIDS...完全的
-
Annamalai UniversityJohns Hopkins Bloomberg School of Public Health; Global Alliance for Improved Nutrition; Department...未知
-
Global Alliance for TB Drug Development终止
-
Global Alliance for TB Drug Development完全的
-
Global Alliance for TB Drug Development完全的
-
Global Alliance for TB Drug Development完全的
-
Global Alliance for TB Drug Development完全的
-
Global Alliance for TB Drug Development完全的
-
Global Alliance for TB Drug Development完全的结核 | 肺结核 | 结核病,多重耐药 | 结核病、耐多药 | 耐药结核病坦桑尼亚, 乔治亚州, 俄罗斯联邦, 巴西, 马来西亚, 菲律宾, 南非, 乌干达
-
Global Alliance for TB Drug Development完全的
-
Global Alliance for TB Drug Development完全的
-
Global Alliance for TB Drug Development招聘中药物敏感结核病 | 肺结核 | 肺结核菲律宾, 南非, 坦桑尼亚, 乔治亚州, 乌干达
-
Global Alliance for TB Drug Development主动,不招人
-
Global Alliance for TB Drug Development完全的利奈唑胺加贝达喹啉和 Pretomanid 的各种剂量和治疗持续时间在患有肺结核、广泛耐药结核病、广泛耐药结核病前或无反应/不耐受耐多药结核病的参与者中的安全性和有效性 (ZeNix) (ZeNix)结核 | 肺结核 | 结核病,多重耐药 | 广泛耐药结核病 | 结核病、耐多药 | 广泛耐药结核病 | 广泛耐药结核前南非, 俄罗斯联邦, 乔治亚州, 摩尔多瓦共和国
-
Global Alliance for TB Drug Development完全的结核 | 肺结核 | 肺病 | 耐多药结核病 | 药物敏感结核病 | 耐药结核病 | 结核分枝杆菌感染美国
-
Global Alliance for TB Drug Development完全的
-
Regeneris MedicalGlobal Alliance for Regenerative Medicine招聘中
-
Swiss Federal Institute of TechnologyUniversity of Zagreb; Global Alliance for Improved Nutrition; UNICEF; St. Luke's Medical Center; Shanxi...完全的
-
Healeon Medical IncGlobal Alliance for Regenerative Medicine撤销
-
Healeon Medical IncGlobal Alliance for Regenerative Medicine暂停
-
University of California, DavisBill and Melinda Gates Foundation; Penn State University; Newcastle University; Helen Keller International 和其他合作者完全的
-
University of California, DavisUnited States Agency for International Development (USAID); Global Alliance for Improved Nutrition 和其他合作者终止
-
Centers for Disease Control and PreventionBayer; Global Alliance for TB Drug Development完全的
-
Robert W Alexander, MDRegeneris Medical; Global Alliance for Regenerative Medicine未知
-
Universitas PadjadjaranRadboud University Medical Center; Global Alliance for TB Drug Development完全的